Franc Llorens

5.5k total citations · 1 hit paper
116 papers, 3.5k citations indexed

About

Franc Llorens is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Franc Llorens has authored 116 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 43 papers in Neurology and 34 papers in Neurology. Recurrent topics in Franc Llorens's work include Prion Diseases and Protein Misfolding (66 papers), Neurological diseases and metabolism (31 papers) and Alzheimer's disease research and treatments (24 papers). Franc Llorens is often cited by papers focused on Prion Diseases and Protein Misfolding (66 papers), Neurological diseases and metabolism (31 papers) and Alzheimer's disease research and treatments (24 papers). Franc Llorens collaborates with scholars based in Spain, Germany and United States. Franc Llorens's co-authors include Isidró Ferrer, Inga Zerr, Matthias Schmitz, José Antonio del Rı́o, Paula Garcia‐Esparcia, Saima Zafar, Eulàlia Martı́, Péter Hermann, Xavier Estivill and Anna Villar‐Piqué and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Franc Llorens

116 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

2021 171 citations Péter Hermann, Michael D. Geschwind et al. profile →

Peers

Countries citing papers authored by Franc Llorens

Since Specialization

Citations

This map shows the geographic impact of Franc Llorens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franc Llorens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franc Llorens more than expected).

Fields of papers citing papers by Franc Llorens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franc Llorens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franc Llorens. The network helps show where Franc Llorens may publish in the future.

Co-authorship network of co-authors of Franc Llorens

This figure shows the co-authorship network connecting the top 25 collaborators of Franc Llorens. A scholar is included among the top collaborators of Franc Llorens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franc Llorens. Franc Llorens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease 2022 ·Molecular Neurobiology ·Matthias Schmitz, (unknown), Juan Carlos Espinosa, Natalia Fernández‐Borges, Anna Villar‐Piqué, Franc Llorens, Daniela Varges, Fabian Maass, Juan María Torres, Péter Hermann, Inga Zerr	8
2	Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline 2022 ·Diagnostics ·(unknown), Péter Hermann, Daniela Varges, (unknown), Stefan Goebel, (unknown), Fabian Maass, Matthias Schmitz, Franc Llorens, Niels Kruse, Paul Lingor, Brit Mollenhauer, Inga Zerr	1
3	Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo 2021 ·Movement Disorders ·(unknown), Matthias Schmitz, (unknown), Angela da Silva Correia, Susana Correia, Franc Llorens, (unknown), Wiebke Möbius, (unknown), Saima Zafar, Erik Stoops, Christopher J. Silva, André Fischer, Tiago F. Outeiro, Inga Zerr	17
4	Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays 2020 ·Translational Neurodegeneration ·Niccolò Candelise, Matthias Schmitz, Katrin Thüne, Maria Cramm, Alberto Rábano, Saima Zafar, Erik Stoops, Hugo Vanderstichele, Anna Villar‐Piqué, Franc Llorens, Inga Zerr	57
5	Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development 2019 ·Proceedings of the National Academy of Sciences ·Sonia M. Vallabh, Chloe K. Nobuhara, Franc Llorens, Inga Zerr, Piero Parchi, Sabina Capellari, Eric Kuhn, Jacob A. Klickstein, Jiri Safar, Flávia C. Nery, Kathryn J. Swoboda, Michael D. Geschwind, Henrik Zetterberg, Steven E. Arnold, Eric Vallabh Minikel, Stuart L. Schreiber	27
6	Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency 2019 ·Molecular Neurobiology ·Matthias Schmitz, Niccolò Candelise, Ειrini Kanata, Franc Llorens, Katrin Thüne, Anna Villar‐Piqué, Susana Correia, Dimitra Dafou, Theodoros Sklaviadis, Dietmar Appelhans, Inga Zerr	14
7	Plasma YKL-40 in the spectrum of neurodegenerative dementia 2019 ·Journal of Neuroinflammation ·Anna Villar‐Piqué, Matthias Schmitz, Péter Hermann, Stefan Goebel, (unknown), Daniela Varges, Isidró Ferrer, J. Riggert, Franc Llorens, Inga Zerr	51
8	CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·Kaj Blennow, Daniela Díaz‐Lucena, Henrik Zetterberg, Anna Villar‐Piqué, André Karch, Enríc Vidal, Péter Hermann, Matthias Schmitz, (unknown), Inga Zerr, Franc Llorens	52
9	Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients 2019 ·Biomolecules ·Inga Zerr, Anna Villar‐Piqué, (unknown), Anna Poleggi, Maurizio Pocchiari, Raquel Sánchez‐Valle, Miguel Calero, Olga Calero, Inês Baldeiras, Isabel Santana, Gábor G. Kovács, Franc Llorens, Matthias Schmitz	10
10	Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy 2018 ·Molecular Neurobiology ·Matthias Schmitz, Anna Villar‐Piqué, Franc Llorens, Karin Gmitterová, Péter Hermann, Daniela Varges, Saima Zafar, Paul Lingor, Hugo Vanderstichele, (unknown), Erik Stoops, John Q. Trojanowski, Virginia M.‐Y. Lee, Inga Zerr	23
11	Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases 2018 ·Molecular Neurobiology ·Anna Villar‐Piqué, Matthias Schmitz, Niccolò Candelise, Salvador Ventura, Franc Llorens, Inga Zerr	17
12	Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia 2018 ·European Archives of Psychiatry and Clinical Neuroscience ·Karin Gmitterová, Joanna Gawinecka, Franc Llorens, Daniela Varges, Peter Valkovič, Inga Zerr	20
13	Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies 2016 ·Molecular Neurobiology ·(unknown), (unknown), Silvia Vilches, Franc Llorens, Katrin Thüne, Juan Carlos Espinosa, Olivier Andréoletti, Alejandro M. Sevillano, Juan María Torres, Jesús R. Requena, Inga Zerr, Isidró Ferrer, Rosalina Gavı́n, José Antonio del Rı́o	2
14	Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage 2015 ·Journal of Molecular Neuroscience ·Saima Zafar, Matthias Schmitz, (unknown), Waqas Tahir, Mohsin Shafiq, Franc Llorens, Isidró Ferrer, (unknown), Inga Zerr	6
15	Gene Expression Resulting from PrPC Ablation and PrPC Overexpression in Murine and Cellular Models 2013 ·Molecular Neurobiology ·Franc Llorens, Isidró Ferrer, José Antonio del Rı́o	6
16	Unraveling the neuroprotective mechanisms of PrP ^C in excitotoxicity 2012 ·Prion ·Franc Llorens, José Antonio del Rı́o	18
17	Neurites regrowth of cortical neurons by GSK3β inhibition independently of Nogo receptor 1 2010 ·Journal of Neurochemistry ·(unknown), Rosalina Gavı́n, Vanessa Gil, Franc Llorens, Alejandra Rangel, Eduardo Soriano, José Antonio del Rı́o	14
18	A myriad of miRNA variants in control and Huntington’s disease brain regions detected by massively parallel sequencing 2010 ·Nucleic Acids Research ·Eulàlia Martı́, Lorena Pantano, Mónica Báñez-Coronel, Franc Llorens, (unknown), Sílvia Porta, Lauro Sumoy, Isidró Ferrer, Xavier Estivill	238
19	The C‐terminal domain of human grp94 protects the catalytic subunit of protein kinase CK2 (CK2α) against thermal aggregation 2001 ·European Journal of Biochemistry ·Nerea Roher, Francesc Miró‐Mur, Brigitte Boldyreff, Franc Llorens, Maria Plana, Olaf‐Georg Issinger, Emilio Itarte	16
20	A randomised double-blind placebo-controlled trial of lidamidine HCL in irritable bowel syndrome. 2000 ·PubMed ·Richard A. Awad, Franc Llorens, (unknown), (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact